Market closed

ATAI Life Sciences/ATAI

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About ATAI Life Sciences

ATAI Life Sciences NV is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Its product candidates include COMP360/Psilocybin therapy, PCN-101/R-ketamine, RL-007/Compound, DMX-1002/Ibogaine, GRX-917/Deuterated etifoxine, VLS-01/DMT, EMP-01/MDMA derivative, RLS-01/Salvinorin A, KUR-101/Deuterated Mitragynine, and DMX-1001/Noribogaine. The business operates geographically in two regions being the United States and Germany.

Ticker

ATAI
Trading on

Industry

Pharmaceuticals
Headquarters

Employees

83

ATAI Metrics

BasicAdvanced
$185M
Market cap
-
P/E ratio
-$0.36
EPS
0.81
Beta
-
Dividend rate
$185M
0.81
$2.85
$1.03
490K
6.683
5.132
11.507
11.649
-37.99%
-27.97%
-31.50%
467.886
1.1
1.1
-2.232
38.97%
-60.97%
-73.31%
-43.17%

What the Analysts think about ATAI

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for ATAI Life Sciences stock.

ATAI Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

ATAI Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy ATAI

$

Sign up or log in to buy
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for ATAI Life Sciences stock?

ATAI Life Sciences (ATAI) has a market cap of $185M as of October 13, 2024.

What is the P/E ratio for ATAI Life Sciences stock?

The price to earnings (P/E) ratio for ATAI Life Sciences (ATAI) stock is 0 as of October 13, 2024.

Does ATAI Life Sciences stock pay dividends?

No, ATAI Life Sciences (ATAI) stock does not pay dividends to its shareholders as of October 13, 2024.

When is the next ATAI Life Sciences dividend payment date?

ATAI Life Sciences (ATAI) stock does not pay dividends to its shareholders.

What is the beta indicator for ATAI Life Sciences?

ATAI Life Sciences (ATAI) has a beta rating of 0.81. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.